Dr. Reddy's Laboratories Files 6-K
Ticker: RDY · Form: 6-K · Filed: Jul 24, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
DRL filed a 6-K, standard reporting for foreign issuers.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 24, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates ongoing compliance and reporting by Dr. Reddy's Laboratories Ltd. with U.S. securities regulations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer of the 6-K
- 0001575872-25-000493 (filing_id) — Accession Number for the filing
- 20250724 (date) — Filing date
- Hyderabad, India (location) — Company's principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information that the registrant has made or is required to make public pursuant to the laws of its home country.
When was this Form 6-K filed?
This Form 6-K was filed on July 24, 2025.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F?
Yes, the filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.
What is the standard industrial classification for Dr. Reddy's Laboratories Ltd.?
The standard industrial classification for Dr. Reddy's Laboratories Ltd. is Pharmaceutical Preparations [2834].
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 24, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).